C12Y 207/01091
Sphinganine kinase
Official title: Sphinganine kinase (2.7.1.91)
C12Y207/01091 (Sphinganine kinase) appears on 15 US grants and 30 published applications in this corpus.
Search patents in C12Y- Granted patents
- 15
- Published applications
- 30
- Assignees
- 19
- Inventors
- 74
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 3 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 2 | 1 |
| 2015 | 0 | 3 |
| 2016 | 2 | 2 |
| 2017 | 1 | 0 |
| 2018 | 0 | 2 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 3 | 4 |
| 2022 | 0 | 2 |
| 2023 | 1 | 0 |
| 2024 | 1 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Anc80 encoding sphingolipid-metabolizing proteins5 May 2026US 12,618,059 B2Icahn School of Medicine at Mount Sinai
- Biomarker for predicting drug resistance of bruton's tyrosine kinase inhibitors and application thereof13 May 2025US 12,297,434 B1Beijing Friendship Hospital, Capital Medical University
- Assays for detecting modified compounds16 Jan 2024US 11,874,281 B2Enzo Life Sciences, Inc.
- Anc80 encoding sphingolipid-metabolizing proteins for mitigating disease-induced tissue damage4 Apr 2023US 11,618,893 B2Icahn School of Medicine at Mount Sinai
- Assays for detecting modified compounds23 Nov 2021US 11,181,528 B2Enzo Life Sciences, Inc.
- Mutant wickerhammyces ciferrll strain having improved productivity for taps, and method for producing taps using same5 Mar 2026US 2026/0062724 A1Korea University Research and Business Foundation
- Assays for detecting modified compounds29 May 2025US 2025/0172466 A1Enzo Life Sciences, Inc.
- Method of regulating pulmonary artery vascular remodeling5 Dec 2024US 2024/0401058 A1The Trustees of Indiana University
- Microorganisms converting inositol to butyrate25 Jan 2024US 2024/0026310 A1Enbiosis Biotechnology Limited
- Treatment and prevention of aging related-disease and/or aging by the inhibition of sphingolipids15 Sep 2022US 2022/0288004 A1Ecole Polytechnique Federale De Lausanne (Epfl)
Most cited
By later US patents
- Biomaterials having nanoscale layers and coatings9US 8,790,678 B2Washington University · 2014
- Antisense modulation of sphingosine-1-phosphate lyase expression5US 6,692,960 B2Isis Pharmaceuticals, Inc. · 2004
- Pichia ciferrii cells and use thereof1US 9,404,118 B2Evonik Degussa GmbH · 2016
- Pichia ciferrii cells and uses thereof1US 9,598,711 B2Evonik Degussa GmbH · 2017